- ISIN
- US7414801073
- CUSIP
- 741480107
- Issuer
- T. Rowe Price
- Inception Date
- Dec 29, 1995
- Category
- Health & Biotech Equities
- Min. Investment
- $2,500
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Large-Cap
- Asset Class Style
- Growth
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PRHSX Performance Chart
T. Rowe Price Health Sciences Fund (PRHSX) is down 1.5% since the beginning of the year. PRHSX is currently trading at $82 per share. Investors who bought $1,000 worth of PRHSX shares 5 years ago would now be looking at an investment worth $1,137.
Loading charts...
Returns By Period
T. Rowe Price Health Sciences Fund (PRHSX) has returned -1.52% so far this year and 22.07% over the past 12 months. Over the last ten years, PRHSX has returned 10.77% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
T. Rowe Price Health Sciences Fund
- 1D
- -0.36%
- 1M
- 0.83%
- YTD
- -1.52%
- 6M
- -2.57%
- 1Y
- 22.07%
- 3Y*
- 6.30%
- 5Y*
- 2.61%
- 10Y*
- 10.77%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PRHSX Monthly Returns History
Based on dividend-adjusted daily data since Jan 2, 1996, PRHSX's average daily return is +0.06%, while the average monthly return is +1.16%. At this rate, an investment would double in approximately 5.0 years.
Historically, 63% of months were positive and 37% were negative. The best month was Jun 2000 with a return of +27.0%, while the worst month was Mar 2000 at -17.8%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, PRHSX closed higher 53% of trading days. The best single day was Oct 13, 2008 with a return of +13.6%, while the worst single day was Mar 16, 2020 at -11.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.98% | 0.64% | -5.91% | 1.60% | 3.54% | -0.16% | -1.52% | ||||||
| 2025 | 6.20% | -1.84% | -4.11% | -0.09% | -6.50% | 3.99% | -1.31% | 4.15% | 2.15% | 7.83% | 9.09% | -1.83% | 17.75% |
| 2024 | 2.05% | 4.06% | 1.66% | -4.97% | 2.31% | 2.85% | 2.68% | 5.19% | -1.95% | -5.00% | 1.49% | -7.62% | 1.82% |
| 2023 | 0.58% | -4.69% | 1.92% | 3.57% | -2.94% | 2.90% | -0.14% | -1.51% | -3.85% | -3.89% | 5.56% | 6.27% | 3.03% |
| 2022 | -12.38% | -0.39% | 4.75% | -8.57% | -0.90% | -0.56% | 5.58% | -3.09% | -4.25% | 7.68% | 4.16% | -3.01% | -12.22% |
| 2021 | 2.35% | -1.82% | -0.77% | 4.95% | -0.92% | 5.61% | 2.02% | 4.16% | -4.66% | 4.21% | -4.90% | 3.22% | 13.50% |
Benchmark Metrics
T. Rowe Price Health Sciences Fund has an annualized alpha of 5.91%, beta of 0.85, and R2 of 0.61 versus S&P 500 Index. Calculated based on daily prices since January 02, 1996.
- This fund participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (98.14%) than losses (78.90%) - typical of diversified or defensive assets.
- This fund generated an annualized alpha of 5.91% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.
- With beta of 0.85 and R2 of 0.61, this fund moves broadly in line with S&P 500 Index - much of its variation is explained by market exposure rather than independent behavior.
- Alpha
- 5.91%
- Beta
- 0.85
- R²
- 0.61
- Upside Capture
- 98.14%
- Downside Capture
- 78.90%
Expense Ratio
PRHSX has an expense ratio of 0.80%, placing it in the medium range.
Return for Risk
Risk / Return Rank
PRHSX ranks 24 for risk / return — below 24% of mutual funds on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRHSX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.65 | ||
| Sortino ratioReturn per unit of downside risk | -0.68 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.37 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 1.68 | 2.78 | -1.10 |
| Martin ratioReturn relative to average drawdown | 4.74 | 12.44 | -7.70 |
Dividends
Dividend History
T. Rowe Price Health Sciences Fund provided a 12.28% dividend yield over the last twelve months, with an annual payout of $10.10 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $10.10 | $10.10 | $10.25 | $4.58 | $1.59 | $7.76 | $7.08 | $10.01 | $4.40 | $5.23 | $2.69 | $7.81 |
Dividend yield | 12.28% | 12.09% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
Monthly Dividends
The table displays the monthly dividend distributions for T. Rowe Price Health Sciences Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.10 | $10.10 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.25 | $10.25 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.58 | $4.58 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.59 | $1.59 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.76 | $7.76 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the T. Rowe Price Health Sciences Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the T. Rowe Price Health Sciences Fund was 42.96%, occurring on Nov 20, 2008. Recovery took 330 trading sessions.
The current T. Rowe Price Health Sciences Fund drawdown is 4.61%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -42.96%Nov 2008 | 10mo 14d | 1y 3mo | 2y 2moJan 2008 - Mar 2010 |
Dot-com crash2000–2002 | -41.17%Jul 2002 | 1y 8mo | 1y 7mo | 3y 4moNov 2000 - Mar 2004 |
Dot-com crash2000–2002 | -29.72%Apr 2000 | 1mo 9d | 2mo 28d | 4mo 7dMar 2000 - Jul 2000 |
COVID crash2020 | -28.97%Mar 2020 | 1mo 2d | 1mo 26d | 2mo 28dFeb 2020 - May 2020 |
Bear market2022 | -27.61%Jun 2022 | 9mo 16d | 2y 2mo | 2y 11moSep 2021 - Aug 2024 |
Drawdown Indicators
| PRHSX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.96% | -56.78% | +13.82% |
Max Drawdown (1Y)Largest decline over 1 year | -12.81% | -9.10% | -3.71% |
Max Drawdown (3Y)Largest decline over 3 years | -21.00% | -18.90% | -2.10% |
Max Drawdown (5Y)Largest decline over 5 years | -27.61% | -25.43% | -2.18% |
Max Drawdown (10Y)Largest decline over 10 years | -28.97% | -33.92% | +4.95% |
Current DrawdownCurrent decline from peak | -4.61% | -1.80% | -2.81% |
Average DrawdownAverage peak-to-trough decline | -8.74% | -10.71% | +1.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.55% | 2.03% | +2.52% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with PRHSX
Add T. Rowe Price Health Sciences Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PRHSX